Discover
TNDM
Tandem Diabetes Care, Inc.
16.11
2 x 14.16
2 x 24.64
bid
ask
+
0.43
2.78%
2 @ 05:30 PM
16.11 +0.00 (0.00%)
| Ytd | -26.71% | |
| 1y | 8.70% |
15.38
day range
16.13
12.82
52 week range
28.26
| Open | 15.65 | Prev Close | 15.68 | Low | 15.38 | High | 16.13 | Mkt Cap | 1.12B |
| Vol | 1.43M | Avg Vol | 2.01M | EPS | -0.91 | P/E | N/A | Forward P/E | 101.35 |
| Beta | 1.66 | Short Ratio | 8.11 | Inst. Own | 115.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 19.39 | 200-d Avg | 19.32 | 1yr Est | 27.86 |
| Income Statement | |||
| Total Revenue | 254.56M | ||
| Revenues (USD) | 254.56M | ||
| Cost of Revenue | 109.78M | ||
| Gross Profit | 144.78M | ||
| Operating Expenses | 158.57M | ||
| Research and Development Expense | 46.93M | ||
| Selling, General and Administrative Expense | 111.64M | ||
| Operating Income | -13.79M | ||
| Interest Expense | 2.45M | ||
| Income Tax Expense | 510.00K | ||
| Net Income | -21.17M | ||
| Net Income Common Stock | -21.17M | ||
| Net Income Common Stock (USD) | -21.17M | ||
| Consolidated Income | -21.17M | ||
| Earnings per Basic Share | -0.31 | ||
| Earnings per Basic Share (USD) | -0.31 | ||
| Earnings per Diluted Share | -0.31 | ||
| Earning Before Interest & Taxes (EBIT) | -18.21M | ||
| Earning Before Interest & Taxes (USD) | -18.21M | ||
| Weighted Average Shares | 69.01M | ||
| Weighted Average Shares Diluted | 69.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 62.82M | ||
| Cash and Equivalents (USD) | 62.82M | ||
| Investments | 525.45M | ||
| Investments Current | 393.18M | ||
| Investments Non-Current | 132.27M | ||
| Trade and Non-Trade Receivables | 162.07M | ||
| Current Assets | 804.64M | ||
| Property, Plant & Equipment Net | 184.69M | ||
| Total Assets | 1.15B | ||
| Debt Current | 20.27M | ||
| Total Debt | 739.25M | ||
| Current Liabilities | 253.01M | ||
| Debt Non-Current | 718.99M | ||
| Total Liabilities | 1.02B | ||
| Accumulated Retained Earnings (Deficit) | -1.29B | ||
| Accumulated Other Comprehensive Income | 6.40M | ||
| Shareholders Equity | 130.39M | ||
| Shareholders Equity (USD) | 130.39M | ||
| Assets Non-Current | 349.56M | ||
| Total Debt (USD) | 739.25M | ||
| Deferred Revenue | 16.21M | ||
| Inventory | 135.11M | ||
| Liabilities Non-Current | 770.81M | ||
| Trade and Non-Trade Payables | 64.13M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.47M | ||
| Net Cash Flow from Financing | 2.15M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -116.51M | ||
| Capital Expenditure | -4.05M | ||
| Net Cash Flow from Investing | -87.34M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -83.29M | ||
| Net Cash Flow from Operations | -34.63M | ||
| Effect of Exchange Rate Changes on Cash | 3.31M | ||
| Share Based Compensation | 15.74M | ||